Back

Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Aggressive ways of saving patients Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marah Hunjul

Nablus (Palestine, State of)

9 More presentations in this session

Presentation thumbnail
Discussant - Aggressive ways of saving patients
Presentation thumbnail
Prognostic significance of histological diagnosis in acute myocarditis with fulminant presentation
Doctor Y. Takei (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Novel semi-invasive pressure-volume loop analysis for hemodynamic assessment and risk stratification across SCAI stages in cardiogenic shock
Doctor J. Ortega-Hernandez (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Impact of the combined use of VA-ECMO and impella (ECPELLA) on short-term mortality in cardiogenic shock patients receiving VA-ECMO: a propensity score-matched analysis
Doctor T. Inamori (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Efficacy and safety of oral acetazolamide in patients with decompensated heart failure: hospital phase of open-label prospective randomized multicenter study ORION-A
Professor I. Sabirov (Bishkek, KG)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Aggressive ways of saving patients

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Pharmacotherapy for worsening heart failure
thumbnail
Congress Session
New tools to detect and treat acute heart failure
thumbnail
Congress Session
Personalised therapy in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources